Showing 1 - 4 results of 4 for search 'Maria Gaia Monti', query time: 0.03s Refine Results
  1. 1
    Doxorubicin impairs the insulin-like growth factor-1 system and causes insulin-like growth factor-1 resistance in cardiomyocytes.

    Doxorubicin impairs the insulin-like growth factor-1 system and causes insulin-like growth factor-1 resistance in cardiomyocytes. by Patrizia Fabbi, Paolo Spallarossa, Silvano Garibaldi, Chiara Barisione, Marzia Mura, Paola Altieri, Barbara Rebesco, Maria Gaia Monti, Marco Canepa, Giorgio Ghigliotti, Claudio Brunelli, Pietro Ameri

    Published 2015-01-01
    Get full text
    Article
  2. 2
    The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin

    The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin by Vincenzo Quagliariello, Michelino De Laurentiis, Domenica Rea, Antonio Barbieri, Maria Gaia Monti, Andreina Carbone, Andrea Paccone, Lucia Altucci, Mariarosaria Conte, Maria Laura Canale, Gerardo Botti, Nicola Maurea

    Published 2021-07-01
    Get full text
    Article
  3. 3
    Myocardial expression of somatotropic axis, adrenergic signalling, and calcium handling genes in heart failure with preserved ejection fraction and heart failure with reduced ejection fraction

    Myocardial expression of somatotropic axis, adrenergic signalling, and calcium handling genes in heart failure with preserved ejection fraction and heart failure with reduced eject... by Roberta D'Assante, Michele Arcopinto, Giuseppe Rengo, Andrea Salzano, Marion Walser, Giuseppina Gambino, Maria Gaia Monti, Leonardo Bencivenga, Alberto M. Marra, David N. Åberg, Carlo De Vincentiis, Andrea Ballotta, Eduardo Bossone, Jörgen Isgaard, Antonio Cittadini

    Published 2021-04-01
    Get full text
    Article
  4. 4
    Pharmacological inhibition of GRK2 improves cardiac metabolism and function in experimental heart failure

    Pharmacological inhibition of GRK2 improves cardiac metabolism and function in experimental heart failure by Michele Ciccarelli, Daniela Sorriento, Antonella Fiordelisi, Jessica Gambardella, Antonietta Franco, Carmine delGiudice, Marina Sala, Maria Gaia Monti, Alessia Bertamino, Pietro Campiglia, Marco Oliveti, Paolo Poggio, Giovanna Trinchese, Gina Cavaliere, Ersilia Cipolletta, Maria Pina Mollica, Domenico Bonaduce, Bruno Trimarco, Guido Iaccarino

    Published 2020-08-01
    Get full text
    Article

Search Tools: